Methylprednisolone sodium succinate reduces BBB disruption and inflammation in a model mouse of intracranial haemorrhage

Highlights • MPSS treatment after ICH reduces BBB disruption and brain oedema. • MPSS also inhibits production of inflammatory cytokines and inflammation in the brain. • MPSS reduces apoptosis in the brain, perhaps by decreasing Bax and increasing Bcl-2. • This suggests that MPSS may be a useful tre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research bulletin 2016-10, Vol.127, p.226-233
Hauptverfasser: Cheng, Shiqi, Gao, WeiWei, Xu, Xin, Fan, Hengyi, Wu, Yingang, Li, Fei, Zhang, Jianning, Zhu, Xingen, Zhang, Yan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • MPSS treatment after ICH reduces BBB disruption and brain oedema. • MPSS also inhibits production of inflammatory cytokines and inflammation in the brain. • MPSS reduces apoptosis in the brain, perhaps by decreasing Bax and increasing Bcl-2. • This suggests that MPSS may be a useful treatment for ICH and result in improved patient prognosis.
ISSN:0361-9230
1873-2747
DOI:10.1016/j.brainresbull.2016.10.007